References
- Moskowitz MA, Lo EH, Iadecola C. The science of stroke: mechanisms in search of treatments. Neuron 2010;67(2):181–98.
- Kleinig TJ, Vink R. Suppression of inflammation in ischemic and hemorrhagic stroke: therapeutic options. Curr Opin Neurol 2009;22(3):294–301.
- Lagowska-Lenard M, Stelmasiak Z, Bartosik-Psujek H. Influence of vitamin C on markers of oxidative stress in the earliest period of ischemic stroke. Pharmacol Rep 2010;62(4):751–6.
- Simani L, Ryan F, Hashemifard Sh, Hooshmandi E, Madahi M, Sahraei Z, et al. Serum Coenzyme Q10 is associated with clinical neurological outcomes in acute stroke patients. J Mol Neurosci 2018:31(3):1–6.
- Lee B-J, Huang Y-C, Chen S-J, Lin P-T. Effects of coenzyme Q10 supplementation on inflammatory markers (high-sensitivity C-reactive protein, interleukin-6, and homocysteine) in patients with coronary artery disease. Nutrition 2012;28(7–8):767–72.
- Abdollahzad H, Aghdashi MA, Asghari Jafarabadi M, Alipour B. Effects of coenzyme Q10 supplementation on inflammatory cytokines (TNF-α, IL-6) and oxidative stress in rheumatoid arthritis patients: a randomized controlled trial. Arch Med Res 2015;46(7):527–33.
- Shults CW, Oakes D, Kieburtz K, Beal MF, Haas R, Plumb S, et al. Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Arch Neurol 2002;59(10):1541–50.
- McGarry A, McDermott M, Kieburtz K, de Blieck EA, Beal F, Marder K, et al. A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease. Neurology 2017;88(2):152–9.
- Yang X, Yang Y, Li G, Wang J, Yang ES. Coenzyme Q10 attenuates β-amyloid pathology in the aged transgenic mice with Alzheimer presenilin 1 mutation. J Mol Neurosci 2008;34(2):165–71.
- Dahri M, Tarighat-Esfanjani A, Asghari-Jafarabadi M, Hashemilar M. Oral coenzyme Q10 supplementation in patients with migraine: effects on clinical features and inflammatory markers. Nutr Neurosci 2018: 1–9.
- Fuller B, Smith D, Howerton A, Kern D. Anti-inflammatory effects of CoQ10 and colorless carotenoids. J Cosmet Dermatol 2006;5(1):30–38.
- Schmelzer C, Lorenz G, Lindner I, Rimbach G, Niklowitz P, Menke T, Döring F. Effects of coenzyme Q_ {10} on TNF-α secretion in human and murine monocytic cell lines. Biofactors 2007;31(1):35–41.
- Kunitomo M, Yamaguchi Y, Kagota S, Otsubo K. Beneficial effect of coenzyme Q10 on increased oxidative and nitrative stress and inflammation and individual metabolic components developing in a rat model of metabolic syndrome. J Pharmacol Sci 2008;107(2):128–37.
- Liu G, Geng J. Glial fibrillary acidic protein as a prognostic marker of acute ischemic stroke. Hum Exp Toxicol 2018;37(10):1048–1053.
- Sharpe PC, Mulholland C, Trinick T. Ascorbate and malondialdehyde in stroke patients. Ir J Med Sci 1994;163(11):488–91.
- Milanlioglu A, Aslan M, Ozkol H, Çilingir V, Nuri Aydın M, Karadas S. Serum antioxidant enzymes activities and oxidative stress levels in patients with acute ischemic stroke: influence on neurological status and outcome. Wien Klin Wochenschr 2016;128(5–6):169–74.
- Simani L, Naderi N, Khodagholi F, Mehrpour M, Nasoohi S. Association of long-term atorvastatin with escalated stroke-induced neuroinflammation in rats. J Mol Neurosci 2017;61(1):32–41.
- Bhagavan HN, Chopra RK. Coenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinetics. Free Radical Res 2006;40(5):445–53.
- Passi S, De Pità O, Puddu P, Littarru GP. Lipophilic antioxidants in human sebum and aging. Free Radical Res 2002;36(4):471–7.
- Allen C, Bayraktutan U. Oxidative stress and its role in the pathogenesis of ischaemic stroke. Int J Stroke 2009;4(6):461–70.
- Nasoohi S, Simani L, Khodagholi F, Nikseresht S, Faizi M, Naderi N. Coenzyme Q10 supplementation improves acute outcomes of stroke in rats pretreated with atorvastatin. Nutr Neurosci 2017: 1–9.
- Wunderlich M, Wallesch C, Goertler M. Release of glial fibrillary acidic protein is related to the neurovascular status in acute ischemic stroke. Eur J Neurol 2006;13(10):1118–23.
- Cherubini A, Polidori MC, Bregnocchi M, Pezzuto S, Cecchetti R, Ingegni T, et al. Antioxidant profile and early outcome in stroke patients. Stroke 2000;31(10):2295–300.
- Demirkaya S, Topcuoglu MA, Aydin A, Ulas UH, Isimer AI, Vural O. Malondialdehyde, glutathione peroxidase and superoxide dismutase in peripheral blood erythrocytes of patients with acute cerebral ischemia. Eur J Neurol 2001;8(1):43–51.
- Belousova MA, Tokareva OG, Gorodetskaya EA, Kalenikova EI, Medvedev OS. Neuroprotective effectiveness of intravenous ubiquinone in rat model of irreversible cerebral ischemia. B Exp Biol Med 2016;161(2):245–47.
- Belousova M, Tokareva OG, Gorodetskaya E, Kalenikova EI, Medvedev OS. Intravenous treatment with coenzyme Q10 improves neurological outcome and reduces infarct volume after transient focal brain ischemia in rats. J Cardiovasc Pharm 2016;67(2):103–9.
- Schmelzer C, Lindner I, Rimbach G, Niklowitz P, Menke T, Döring F. Functions of coenzyme Q10 in inflammation and gene expression. Biofactors 2008;32(1–4):179–83.
- Fu ES, Zhang YP, Sagen J, Candiotti KA, Morton PD, Liebl DJ, et al. Transgenic inhibition of glial NF-kappa B reduces pain behavior and inflammation after peripheral nerve injury. PAIN® 2010;148(3):509–18.
- Lee D, Shim MS, Kim K-Y, Noh YH, Kim H, Kim SY, et al. Coenzyme Q10 inhibits glutamate excitotoxicity and oxidative stress–mediated mitochondrial alteration in a mouse model of glaucoma. Invest Ophth Vis Sci 2014;55(2):993–1005.
- Lee B-J, Tseng Y-F, Yen C-H, Lin P-T. Effects of coenzyme Q10 supplementation (300 mg/day) on antioxidation and anti-inflammation in coronary artery disease patients during statins therapy: a randomized, placebo-controlled trial. Nutr J 2013;12(1):142.
- Liu J, Wang L, Zhan Si, Xia Y. Coenzyme Q10 for Parkinson’s disease. Cochrane Database Syst Rev 2011;12.
- Storch A, Jost W, Vieregge P, Spiegel J, Greulich W, Durner J, et al. Randomized, double-blind, placebo controlled trial on symptomatic effects of coenzyme Q10 in Parkinson disease. Arch Neurol 2007;64(7):938–44.
- Investigators HSGPC. Safety and tolerability of high-dosage coenzyme Q10 in Huntington’s disease and healthy subjects. Mov Disord 2010;25(12):1924–28.
- Groneberg DA, Kindermann B, Althammer M, Klapper M, Vormann J, Littarru GP, et al. Coenzyme Q10 affects expression of genes involved in cell signalling, metabolism and transport in human CaCo-2 cells. Int J Biochem Cell Biol 2005;37(6):1208–18.